Going forward it will be important to test the same effect described here for PARP stimulation in Rett organoids and transgenic animals lacking MECP2 to further define the clinical relevance for this pathway in the etiology of Rett syndrome. The gene discussed is PARP1; the disease is Rett syndrome.